The effect of ferric carboxymaltose treatment on the Tp-e interval and the Tp-e/QT and Tp-e/QTc ratios in heart failure patients with iron deficiency

Aim    In heart failure (HF) patients with iron deficiency, cardiac electrical irregularity is a cause of arrhythmias. The aim of our study was to evaluate the effect of ferric carboxymaltose (FCM) treatment on T wave peak to end (Tp-e) interval and the Tp-e / QT and Tp-e / corrected QT (QTc) ratios that reflect the transmural dispersion of repolarization in HF patients with iron deficiency.
Material and methods    Forty HF patients with iron deficiency that were treated with FCM were included in our single center, observational study. Repolarization parameters on electrocardiograms recorded before and 12 wks after FCM treatment were compared. Additionally, these parameters were compared with ventricular repolarization parameters of 40 healthy age and gender matched individuals and with another group of 40 HF patients without iron deficiency.
Results    In the HF patients with iron deficiency, the Tp-e interval and the Tp-e / QT and Tp-e / QTc ratios before FCM treatment were 103.7±19.1 ms, 0.25± 0.04, 0.23±0.04, respectively. These values were higher compared to the healthy the group and HF group without iron deficiency (p<0.001). In the HF patients with iron deficiency, the Tp-e interval and the Tp-e / QT and Tp-e / QTc ratios after FCM treatment were lower compared to pre-treatment and similar to the HF patients without iron deficiency (89.4±18.6 ms, 0.22±0.04, 0.20±0.04, respectively; p<0.001).
Conclusion    FCM treatment of HF patients with iron deficiency corrects prolonged Tp-e interval and high Tp-e / QT and Tp-e / QTc ratios, which are risk factors for ventricular arrhythmias.

1. Klip IjT, Comin-Colet J, Voors AA, Ponikowski P, Enjuanes C, Banasiak W et al. Iron deficiency in chronic heart failure: An international pooled analysis. American Heart Journal. 2013;165(4):575-582.e3. DOI: 10.1016/j.ahj.2013.01.017

2. Anand IS, Gupta P. Anemia and Iron Deficiency in Heart Failure: Current Concepts and Emerging Therapies. Circulation. 2018;138(1):80–98. DOI: 10.1161/CIRCULATIONAHA.118.030099

3. Okonko DO, Mandal AKJ, Missouris CG, Poole-Wilson PA. Disordered Iron Homeostasis in Chronic Heart Failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival. Journal of the American College of Cardiology. 2011;58(12):1241–51. DOI: 10.1016/j.jacc.2011.04.040

4. Anker SD, Colet JC, Filippatos G, Willenheimer R, Dickstein K, Drexler H et al. Rationale and design of Ferinject® Assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia. European Journal of Heart Failure. 2009;11(11):1084–91. DOI: 10.1093/eurjhf/hfp140

5. Ponikowski P, van Veldhuisen DJ, Comin-Colet J, Ertl G, Komajda M, Mareev V et al. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency. European Heart Journal. 2015;36(11):657–68. DOI: 10.1093/eurheartj/ehu385

6. Ponikowski P, Kirwan B-A, Anker SD, McDonagh T, Dorobantu M, Drozdz J et al. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial. Lancet (London, England). 2020;396(10266):1895–904. DOI: 10.1016/S0140-6736(20)32339-4

7. Porthan K, Viitasalo M, Toivonen L, Havulinna AS, Jula A, Tikkanen JT et al. Predictive Value of Electrocardiographic T-Wave Morphology Parameters and T-Wave Peak to T-Wave End Interval for Sudden Cardiac Death in the General Population. Circulation: Arrhythmia and Electrophysiology. 2013;6(4):690–6. DOI: 10.1161/CIRCEP.113.000356

8. Dogan M, Yiginer O, Degirmencioglu G, Un H. Transmural dispersion of repolarization: a complementary index for cardiac inhomogeneity. Journal of geriatric cardiology: JGC. 2016;13(1):99–100. DOI: 10.11909/j.issn.1671-5411.2016.01.012

9. Morin DP, Saad MN, Shams OF, Owen JS, Xue JQ, Abi-Samra FM et al. Relationships between the T-peak to T-end interval, ventricular tachyarrhythmia, and death in left ventricular systolic dysfunction. Europace. 2012;14(8):1172–9. DOI: 10.1093/europace/eur426

10. Cappellini MD, Comin-Colet J, de Francisco A, Dignass A, Doehner W, Lam CS et al. Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management. American Journal of Hematology. 2017;92(10):1068–78. DOI: 10.1002/ajh.24820

11. Kilicaslan F, Tokatli A, Ozdag F, Uzun M, Uz O, Isilak Z et al. Tp-e interval, Tp-e/QT ratio, and Tp-e/QTc ratio are prolonged in patients with moderate and severe obstructive sleep apnea. Pacing and clinical electrophysiology: PACE. 2012;35(8):966–72. DOI: 10.1111/j.1540-8159.2012.03439.x

12. Yeo TJ, Yeo PSD, Ching-Chiew Wong R, Ong HY, Leong KTG, Jaufeerally F et al. Iron deficiency in a multi-ethnic Asian population with and without heart failure: prevalence, clinical correlates, functional significance and prognosis. European Journal of Heart Failure. 2014;16(10):1125–32. DOI: 10.1002/ejhf.161

13. Jankowska EA, Rozentryt P, Witkowska A, Nowak J, Hartmann O, Ponikowska B et al. Iron deficiency: an ominous sign in patients with systolic chronic heart failure. European Heart Journal. 2010;31(15):1872–80. DOI: 10.1093/eurheartj/ehq158

14. Antzelevitch C. Role of spatial dispersion of repolarization in inherited and acquired sudden cardiac death syndromes. American Journal of Physiology-Heart and Circulatory Physiology. 2007;293(4):H2024–38. DOI: 10.1152/ajpheart.00355.2007

15. Bounhoure JP, Galinier M, Boveda S, Albenque J-P. Ventricular arrhythmias, sudden death and heart failure. Bulletin De l’Academie Nationale De Medecine. 2010;194(6):997–1007. PMID: 21513134

16. Panikkath R, Reinier K, Uy-Evanado A, Teodorescu C, Hattenhauer J, Mariani R et al. Prolonged Tpeak-to-Tend Interval on the Resting ECG Is Associated With Increased Risk of Sudden Cardiac Death. Circulation: Arrhythmia and Electrophysiology. 2011;4(4):441–7. DOI: 10.1161/CIRCEP.110.960658

17. Hegde N, Rich MW, Gayomali C. The cardiomyopathy of iron deficiency. Texas Heart Institute Journal. 2006;33(3):340–4. PMID: 17041692

18. Watanabe N, Kobayashi Y, Tanno K, Miyoshi F, Asano T, Kawamura M et al. Transmural dispersion of repolarization and ventricular tachyarrhythmias. Journal of Electrocardiology. 2004;37(3):191–200. DOI: 10.1016/j.jelectrocard.2004.02.002

19. Letsas KP, Weber R, Astheimer K, Kalusche D, Arentz T. Tpeak-Tend interval and Tpeak-Tend/QT ratio as markers of ventricular tachycardia inducibility in subjects with Brugada ECG phenotype. Europace. 2010;12(2):271–4. DOI: 10.1093/europace/eup357

20. Smetana P, Schmidt A, Zabel M, Hnatkova K, Franz M, Huber K et al. Assessment of repolarization heterogeneity for prediction of mortality in cardiovascular disease: peak to the end of the T wave interval and nondipolar repolarization components. Journal of Electrocardiology. 2011;44(3):301–8. DOI: 10.1016/j.jelectrocard.2011.03.004

21. Topilski I, Rogowski O, Rosso R, Justo D, Copperman Y, Glikson M et al. The Morphology of the QT Interval Predicts Torsade de Pointes During Acquired Bradyarrhythmias. Journal of the American College of Cardiology. 2007;49(3):320–8. DOI: 10.1016/j.jacc.2006.08.058

22. Gupta P, Patel C, Patel H, Narayanaswamy S, Malhotra B, Green JT et al. Tp-e/QT ratio as an index of arrhythmogenesis. Journal of Electrocardiology. 2008;41(6):567–74. DOI: 10.1016/j.jelectrocard.2008.07.016

23. Laudanski K, Ali H, Himmel A, Godula K, Stettmeier M, Calvocoressi L. The relationship between serum ferritin levels and electrocardiogram characteristics in acutely ill patients. Experimental and Clinical Cardiology. 2009;14(3):38–41. PMID: 20098576

24. Toblli JE, Lombraña A, Duarte P, Di Gennaro F. Intravenous Iron Reduces NT-Pro-Brain Natriuretic Peptide in Anemic Patients With Chronic Heart Failure and Renal Insufficiency. Journal of the American College of Cardiology. 2007;50(17):1657–65. DOI: 10.1016/j.jacc.2007.07.029

25. Toblli JE, Di Gennaro F, Rivas C. Changes in Echocardiographic Parameters in Iron Deficiency Patients with Heart Failure and Chronic Kidney Disease Treated with Intravenous Iron. Heart, Lung and Circulation. 2015;24(7):686–95. DOI: 10.1016/j.hlc.2014.12.161

26. Martens P, Dupont M, Dauw J, Nijst P, Herbots L, Dendale P et al. The effect of intravenous ferric carboxymaltose on cardiac reverse remodelling following cardiac resynchronization therapy – the IRONCRT trial. European Heart Journal. 2021;42(48):4905–14. DOI: 10.1093/eurheartj/ehab411

27. Yilmaz E, Aydin E. The effect of low iron storage without Anaemia on electrocardiography. Journal of Electrocardiology. 2021;64:76–9. DOI: 10.1016/j.jelectrocard.2020.11.015